info@skinbiotherapeutics.com | +44 161 468 2760

SkinBioTherapeutic
SkinBioTherapeutic
Menu
  • Home
  • Technology
  • Applications
  • Sectors
  • About us
  • Team
  • News & Articles
  • Investor Relations
  • Contact us
Company news, Presentations

CEO presentation at Shares investor event

30th November 2020 3:37 pm30th November 2020

Previous ArticleDoug Quinn, CFO, updates on the Proposed Placing and Open OfferNext ArticleSKINBIOTHERAPEUTICS PLC SELECTS DATITUDE AS ITS DATA PARTNER FOR A FOOD SUPPLEMENT HUMAN STUDY

Articles

  • Expanded enrolment for AxisBiotix-PsTM food supplement consumer study
  • CEO Stuart Ashman discusses enrolment for the AxisBiotix food supplement study
  • Food supplement consumer study

Links

  • Home
  • Technology
  • Applications
  • Sectors
  • About us
  • Team
  • News & articles
  • Investor Relations
  • Contact us
  • Privacy Policy

Contact

SkinBioTherapeutics PLC
15 Silk House
Park Green
Macclesfield
SK11 7QJ

+44 161 468 2760

AxisBiotix is a wholly owned subsidiary of SkinBioTherapeutics PLC

www.axisbiotix.com

© 2017-2020 SkinBioTherapeutics PLC | All Rights Reserved

Menu
  • Home
  • Technology
  • Applications
  • Sectors
  • About us
  • Team
  • News & Articles
  • Investor Relations
  • Contact us
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkPrivacy policy